Neuroone Medical Technologies (NMTC) Total Current Liabilities (2010 - 2026)

Neuroone Medical Technologies (NMTC) has reported Total Current Liabilities for 17 consecutive years, with $2.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Current Liabilities rose 43.18% year-over-year to $2.0 million; the trailing twelve-month figure through Jun 2026 stood at $2.0 million (up 43.18% YoY), and the FY2025 full-year result was $2.3 million, up 4.06% from the prior year.
• Total Current Liabilities climbed to $2.0 million in Q2 2026 per NMTC's latest filing, from $1.7 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $3.1 million in Q3 2022 and bottomed at $810231.0 in Q1 2022.
• Historically, Total Current Liabilities has averaged $1.7 million across 5 years, with a median of $1.6 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Total Current Liabilities surged 162.22% in 2022, then slumped 42.15% in 2023.
• Over 5 years, Total Current Liabilities stood at $1.3 million in 2022, then rose by 3.63% to $1.4 million in 2023, then increased by 13.57% to $1.6 million in 2024, then decreased by 19.89% to $1.3 million in 2025, then surged by 62.22% to $2.0 million in 2026.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $2.0 million, $1.7 million, and $1.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.